SCHEMBL7980965

SCHEMBL7980965

CC(C)(Oc1ccc(F)c(F)c1)C(=O)NN

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
ADORA2A P29274 2/20 0.42
PPARA Q07869 3/20 0.42
ADORA3 P0DMS8 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C9 P11712 2/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD11B1 P28845 1/20 0.39
HSD11B2 P80365 1/20 0.39
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
FBP1 P09467 1/20 0.38
CNR1 P21554 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1417420 0.98 ADORA2A (0.42) ALDH1A1ADORA2APPARAADORA3ADORA2B
SCHEMBL7991796 0.88 HDAC1 (0.40) ALDH1A1ADORA2APPARAADORA3ADORA2B
SCHEMBL12670848 0.83 AR (0.41) CYP2C19CYP2D6CYP2C9
SCHEMBL1417538 0.82 ALDH1A1 (0.49) ALDH1A1ADORA2APPARAADORA3ADORA2B
SCHEMBL25214405 0.81 FBP1 (0.44) ADORA2APPARAADORA3ADORA2BADORA1
SCHEMBL31067884 0.81 FBP1 (0.44) ADORA2APPARAADORA3ADORA2BADORA1
SCHEMBL1418013 0.80 PPARA (0.61) ALDH1A1PPARACYP1A2CYP3A4CYP2C19
SCHEMBL31067899 0.80 PPARA (0.61) ALDH1A1PPARACYP1A2CYP3A4CYP2C19
SCHEMBL7994910 0.80 CNR1 (0.48) ALDH1A1ADORA2APPARAKMT2AMAOB
SCHEMBL7974279 0.79 CNR1 (0.43) ALDH1A1PPARACYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8377923-B2 Triazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2013-02-19 US disclosed
US-8377923-B2 Triazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2013-02-19 US disclosed
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2011-05-05 US disclosed
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2011-05-05 US disclosed
WO-2010001946-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF アステラス製薬株式会社 (JP) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF HSD11B1, HSD11B2, HSD3B1 ALDH1A1 359/4885ADORA2A 4108/4885PPARA 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.